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Background
The emergence of ribotype 027 increased the severity of
Clostridium difficile infection (CDI). Fast severity assessing
plays an essential role in decreasing the mortality due to
CDI; early surgery is the best intervention to decrease the
lethality in severe CDI with toxic megacolon. Several
severity scores were defined, including the ATLAS score,
but the validation studies were performed in developed
countries with structured medical practice. We evaluated
the usefulness of ATLAS score and of its components as
indicators for CDI severity (deaths, length-of-stay, costs).
Methods
We calculated in a retrospective manner the ATLAS score
for 170 consecutive patients with CDI, admitted in the
National Institute for Infectious Diseases “Prof. Dr. Matei
Balş” during a seven months period, September 2012 to
March 2013. The mean and median values for parameters
of ATLAS score as the score itself were compared for sur-
vivor (S; n=159 patients) and non-survivor (NS; n=11)
groups.
Results
The median value of ATLAS score was significantly higher
in the non-survivors as in survivors: 6 versus 3, p=0.00002.
The highest relative risk of death was associated with a
value of ATLAS score of 5 or more, RR = 16.46 (95% CI:
3.69-73.46; p=0.0002). The patients in NS group were
older: 79 years versus 64.1 years (p=0.000076), had a
greater value of highest temperature: 38.7°C versus 37.9°C
(p=0.00028), and a lower level of initial albuminemia:
2.33 g/dL versus 3.12 g/dL (p=0.00044). For the initial
WBC count the value is greater in NS group, with almost
defined statistical significance: 21,918/cmm versus 12,130/
cmm (p=0.071). Concomitant systemic antibiotic treat-
ment was prescribed in 5 of 11 patients in NS group and
in 48 of 159 patients in S group, p=0.29; the overall conco-
mitant systemic antibiotic use was 32.1%, greater than in
the validation study of ATLAS score (19%). The mean
duration of hospitalization in all patients was 12.5 days;
the value of ATLAS score was also positively correlated to
the length-of-stay, R2=0.922. The mean cost of medication
was 2697.4±4685.55 RON (range 25-31254 RON); the
value of ATLAS score had a good correlation with medi-
cation costs: R²=0.732, p=0.003.
Conclusion
The ATLAS score confirmed its value as predictor of
outcome in CDI patients, for lethality, lenght-of-stay
and direct costs of medication. Among ATLAS score
parameters, only simultaneous CDI treatment and sys-
temic antibiotics use was not significantly different in S
and NS groups, due to the large extent of systemic anti-
biotic treatment in our patients.
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